4//SEC Filing
Gao Hanlin 4
Accession 0000950170-25-032772
CIK 0001674930other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:06 PM ET
Size
4.9 KB
Accession
0000950170-25-032772
Insider Transaction Report
Form 4
Gao Hanlin
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-03-01$15.45/sh−985$15,218→ 964,310 total
Footnotes (1)
- [F1]The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 28, 2022, which grants were originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 2, 2022.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001684532
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:06 PM ET
- Size
- 4.9 KB